Long-haul COVID

A 78-year-old male with a history of long-haul COVID (or post-COVID conditions) after
his first COVID infection in August 2020, presented with persistent symptoms of brain
fog, poor concentration, anxiety, depression, fatigue, malaise, and exercise intolerance.
Since the initial infection, he has undergone multiple treatments including IV vitamin
therapies, ozone therapy, and over 50 sessions of hyperbaric oxygen therapy, all of
which provided only temporary relief. From 2021 to 2024, he completed eight EBOO
(extracorporeal blood oxygenation & ozonation) treatments, resulting in mild
improvements. Despite these interventions, his energy and cognitive function remained
significantly impaired.

From 2024 to 2025, the patient underwent five IV stem cell therapies with umbilical
cord–derived stem cells (250 million native non-expanded cells) combined with
exosomes. The therapies were well tolerated without complications.

Following treatments, the patient reported sustained and marked improvement in his
overall condition. He now experiences greater endurance and no longer feels fatigued
after routine morning activities such as showering, eating breakfast, or completing
household chores. He notes improved energy, cognition, and mood, with resolution of
anxiety, brain fog, and tinnitus. His speech, memory, and general strength have returned
to baseline for his age, and he continues to feel well with no recurrence of prior
symptoms.